All Articles

Rebranding from nanotech to lithium, Summit completes a key engineering step for its modular extraction plants, poised to tackle the global lithium shortage.

China's energy giant uses a five-country open day to showcase green tech, but its strategy reveals a complex mix of education, soft power, and a debated energy portfolio.

A new partnership aims to solve enterprise AI's biggest hurdle: deploying governed systems in industries where compliance is non-negotiable.

A plant-based bomber jacket is hitting the mainstream. Is this the blueprint for fashion's sustainable future or just another high-profile experiment?

A breakthrough system grows larger, more complex human gut tissues twice as fast, promising to revolutionize drug testing and regenerative medicine.

A revolutionary single-dose, over-the-counter cold sore tablet launches in Europe, promising new convenience for millions and shaking up the self-care market.

Caliway Biopharma advances its fat-loss drug, promising objective, MRI-verified results in a market hungry for safer, more reliable aesthetic options.

Gene Solutions' AI-driven multi-omics liquid biopsy platform makes waves at a major oncology conference, finding a ready market in Taiwan.

A Fresno firm is challenging traditional retirement planning by putting personal goals first, aiming for more meaningful and financially secure futures.

Purecore Metals launches a major exploration program for critical minerals in BC while committing heavily to market-making and investor awareness.

A North Carolina firm is tackling the two biggest threats to retirement security: soaring healthcare costs and taxes. Here's how their tech-driven plan works.

FortuneX Acquisition Corp. raised $75M in its IPO, but it enters a SPAC market wary of past failures and facing stricter regulatory oversight.

Starlight Capital's new offering provides investors a 6.85% yield, tapping into demand for real assets while funding a strategic reorganization.

South Korea's KT SAT pivots from satellite operator to a 'Total Space Solution Provider,' integrating networks to chase sovereign security and universal access.

Pliant Therapeutics heads to ASCO with data on a novel drug designed to reawaken the immune system's attack on advanced, treatment-resistant tumors.

New data shows Moleculin Biotech's Annamycin avoids heart toxicity, a breakthrough that could transform treatment for leukemia and sarcoma patients.

South Korean food leader Binggrae uses THAIFEX 2026 to launch a strategic assault on Southeast Asia with localized flavors and a diversified portfolio.

A wave of severe storms has forced homeowners to replace aging roofs, revealing a hidden crisis of deferred maintenance and overwhelming local contractors.

A Singaporean group just bought a century-old Milanese tailor. Can 3D scanning and global ambition coexist with a legacy built on the motto 'Never bend'?

A new partnership between Riverchain and Micro Connect uses AI and a novel funding model to inject vital capital into Hong Kong's construction industry.